← Back to home
Comparison · Analytics

DoseFinding vs webmockr

A side-by-side editorial comparison of DoseFinding and webmockr — release velocity, themes, recent moves, and the top alternatives to consider.

DoseFinding vs webmockr: at a glance

FeatureDoseFindingwebmockr
SectorAnalyticsAnalytics
Velocity score0.00.0
Sparks · 30d00
Top themesdose-response, mcp-mod, clinical-trials, model-averaginghttp-mocking, testing, httr2, ropensci
Last editorial update1h ago1h ago
WebsiteVisit →Visit →

What is DoseFinding?

New stewardship at openpharma, then two releases adding the methods MCP-Mod was missing

DoseFinding implements MCP-Mod and related dose-response methodology for clinical trial design and analysis. In 2024 it changed hands — Marius Thomas took over as maintainer, Novartis was recorded as copyright holder and funder, and the package moved to the openpharma GitHub organisation with roxygen documentation and a proper NEWS file. The two releases since have added substantive methodology: model averaging for dose-response fitting in 1.3-1, and conditional and predictive power for interim analyses in 1.4-1.

Read the full DoseFinding trajectory →

What is webmockr?

The stubbing library added httr2 support, then spent a year cutting itself free of everything else

webmockr intercepts HTTP requests in R tests and returns stubbed responses, and since 1.0.0 it covers all three clients that matter — httr, httr2 and crul. The releases through 2025 have been about shedding dependencies: internal R6 classes unexported in 2.1.0, crul demoted from Imports to Suggests in the same release, and the mutual dependency with vcr severed in 2.2.0. The package now installs and runs without pulling in the rest of the rOpenSci HTTP stack.

Read the full webmockr trajectory →

DoseFinding vs webmockr: editorial side-by-side

D
DoseFinding
ANALYTICS
0.0

New stewardship at openpharma, then two releases adding the methods MCP-Mod was missing

◆ Current state

DoseFinding implements MCP-Mod and related dose-response methodology for clinical trial design and analysis. In 2024 it changed hands — Marius Thomas took over as maintainer, Novartis was recorded as copyright holder and funder, and the package moved to the openpharma GitHub organisation with roxygen documentation and a proper NEWS file. The two releases since have added substantive methodology: model averaging for dose-response fitting in 1.3-1, and conditional and predictive power for interim analyses in 1.4-1.

◆ Where it's heading

The pattern before the handover was maintenance — R-devel compliance, a bug fix, a link. After it, each release carries a named methodological addition with an acknowledged contributor, plus documentation to match: a longitudinal analysis vignette shipped alongside the interim power work. Housekeeping continues underneath, mostly clearing deprecated ggplot2 interfaces, aes_string in one release and qplot in the next.

◆ Prediction

Given the last two releases each added one method with a supporting vignette, expect the next to follow the same shape. Both additions so far extend the package beyond fixed dose-response fitting, so adaptive and interim methodology is the more likely direction.

W
webmockr
ANALYTICS
0.0

The stubbing library added httr2 support, then spent a year cutting itself free of everything else

◆ Current state

webmockr intercepts HTTP requests in R tests and returns stubbed responses, and since 1.0.0 it covers all three clients that matter — httr, httr2 and crul. The releases through 2025 have been about shedding dependencies: internal R6 classes unexported in 2.1.0, crul demoted from Imports to Suggests in the same release, and the mutual dependency with vcr severed in 2.2.0. The package now installs and runs without pulling in the rest of the rOpenSci HTTP stack.

◆ Where it's heading

Two arcs run in sequence. The first is coverage — multiple queued responses in 0.7.0, basic auth mocking, async through crul, then httr2 — building out what can be stubbed. The second, starting with 2.0.0, is correctness and independence: stubs are now deleted if an error occurs mid-construction rather than lingering half-built, partial matching arrives for bodies and queries, and the dependency graph is pruned release by release. The 2.2.0 split from vcr landed within a minute of crul's release taking mocking control into its own clients.

◆ Prediction

RequestPattern is documented as still exported in 2.1.0 but slated for removal, so the next major release is where that lands. Expect continued dependency pruning rather than new client support — the three clients that exist are already covered.

Alternatives to DoseFinding and webmockr

Other Analytics products tracked by Sparkpulse, ranked by recent ship velocity. Each card links to a full editorial trajectory and lets you pivot into a head-to-head comparison with either DoseFinding or webmockr.

See all DoseFinding alternatives → · See all webmockr alternatives →

Recent activity from DoseFinding and webmockr

Latest ship moves from both products, interleaved chronologically. ⚡ = editorial spark.

  1. 1y agowebmockrvcr dependency severed
  2. 1y agoDoseFindingConditional and predictive power for interim analyses
  3. 1y agowebmockrInternal classes unexported; crul becomes an optional dependency
  4. 1y agoDoseFindingModel averaging arrives for dose-response fitting
  5. 1y agowebmockrFailed stub construction cleans up; partial matching extends to bodies and queries
  6. 1y agoDoseFindingPackage moves to openpharma under new maintainership
  7. 2y agowebmockrhttr2 joins httr and crul as a supported client
  8. 2y agoDoseFindingCompliance update for R-devel
  9. 3y agoDoseFindingpowMCTBinCount bug fix
  10. 3y agowebmockrQueued responses, body matching and integer status codes fixed
  11. 3y agowebmockrRegex URI matching fixed

Frequently asked questions

What is the difference between DoseFinding and webmockr?

They serve adjacent needs but don't currently overlap on shipped themes. DoseFinding and webmockr are shipping at a similar cadence (velocity 0.0 vs 0.0, both within Sparkpulse's "active" band). See the at-a-glance table above for a side-by-side breakdown of velocity, recent sparks, and editorial themes.

Is DoseFinding better than webmockr?

Sparkpulse doesn't pick a winner — we score release velocity, not feature parity. DoseFinding and webmockr are shipping at a similar cadence (velocity 0.0 vs 0.0, both within Sparkpulse's "active" band). For your specific use case, the alternatives sections above list other Analytics products to evaluate alongside.

What are the best alternatives to DoseFinding?

Top DoseFinding alternatives in Analytics are ranked by recent ship velocity. Browse the "DoseFinding alternatives" section above for the current picks, or visit /alternatives/dosefinding for the full list with editorial commentary on each.

What are the best alternatives to webmockr?

Top webmockr alternatives in Analytics are ranked by recent ship velocity. Browse the "webmockr alternatives" section above for the current picks, or visit /alternatives/webmockr for the full list with editorial commentary on each.